7 completed, 3 terminated, 1 not yet recruiting, 1 recruiting. 4 Not applicable, 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Terminated 2, Completed 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow Lymphocyte Count: new trials by email Literature Review of Lymphocyte Count trials Research Report on Lymphocyte Count
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome • Complete blood count , MPV, Calculation of PLR: Platelet count / Lymphocyte count and Calculation of NLR:, Antiphospholipid antibody profile - Antiphospholipid Syndrome | Recruiting | New Valley University | 150 | 2025-11-27 | 2026-07-31 | |
| Relation Between Lymphocyte-to-C-Reactive Protein Ratio and Coronary Artery Disease Complexity No intervention administered. Standard care will be provided. Blood samples for lymphocyte count and CRP will be collected, and Syntax score will be calculated from angiography. - Coronary Artery Disease | Not yet recruiting | Assiut University | 600 | 2025-06-03 | 2025-05-06 | |
| Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention. Mean platelet volume, lymphocyte number, STEMI clinical risk scores - No-Reflow Phenomenon | Completed | Assiut University | 640 | 2020-09-01 | 2024-05-31 | |
| Lymphocytes Subpopulation in Cancer Patients lymphocyte - Cancer | Not applicable | Unknown | DERSHENG SUN | 100 | 2015-08-01 | 2015-08-26 |
| The Circulating Fibrocyte - a Novel and Accurate Biomarker in Diagnosing Acute Appendicitis in Adults Circulating fibrocytes - Appendicitis | Completed | University Hospital of Limerick | 95 | 2015-06-10 | 2019-06-17 | |
| Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Patients lymphocyte count - Lymphopenia | Completed | University of Sao Paulo | 14 | 2014-02-01 | 2016-03-04 | |
| Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma Surgery, Administration of Lymphodepletion, Adoptive Cell Transfer - Metastatic Melanoma | Not applicable | Completed | H. Lee Moffitt Cancer Center and Research Institute | 19 | 2009-10-20 | 2025-12-19 |
| Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies Rituximab, Cyclophosphamide, Fludarabine - Leukemia, Lymphoma | Phase 1 | Terminated | M.D. Anderson Cancer Center | 4 | 2007-05-01 | 2011-12-19 |
| Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer Natural Killer (NK) Lymphocytes, IL-2, Cyclophosphamide - Metastatic Melanoma, Metastatic Kidney Cancer | Phase 2 | Completed | National Cancer Institute (NCI) | 8 | 2006-05-01 | 2012-11-05 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia aldesleukin, therapeutic allogeneic lymphocytes, cyclophosphamide - Leukemia | Phase 2 | Completed | Masonic Cancer Center, University of Minnesota | 21 | 2005-03-01 | 2017-12-28 |
| Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection Indinavir sulfate, Diphenhydramine hydrochloride, Lymphocytes, Activated - HIV Infections | Not applicable | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 16 | 2016-12-14 | |
| A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients Lymphocytes, Activated - HIV Infections | Not applicable | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-12-14 | ||
| Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3 Lymphocytes, Activated - HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2021-11-03 |
HIV Infections (3) · Leukemia (2) · Melanoma (2) · AIDS-Related Complex (1) · Acquired Immunodeficiency Syndrome (1) · Antiphospholipid Syndrome (1) · Appendicitis (1) · Congenital Abnormalities (1) · Coronary Artery Disease (1) · Graft vs Host Disease (1) · Kidney Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Lymphopenia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Assiut University (2) · DERSHENG SUN (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · M.D. Anderson Cancer Center (1) · Masonic Cancer Center, University of Minnesota (1) · National Cancer Institute (NCI) (1) · New Valley University (1) · University Hospital of Limerick (1) · University of Sao Paulo (1)
United States (7) · Egypt (2) · Ireland (1) · South Korea (1)
Amod Sarnaik, M.D. (1) · D Stein (1) · H Standiford (1) · J Lieberman (1) · Jeffrey Miller, MD (1) · Richard E. Champlin, MD (1) · Yoon Ho Ko, MD, PhD (1)